| 前收盘价格 | 2.75 |
| 收盘价格 | 3.05 |
| 成交量 | 4,804,743 |
| 平均成交量 (3个月) | 2,130,124 |
| 市值 | 62,364,872 |
| 价格/销量 (P/S) | 1.17 |
| 52周波幅 | |
| 利润日期 | 25 Mar 2025 - 31 Mar 2025 |
| 营业毛利率 | -40.78% |
| 营业利益率 (TTM) | -10.84% |
| 稀释每股收益 (EPS TTM) | -0.630 |
| 季度收入增长率 (YOY) | 137.60% |
| 流动比率 (MRQ) | 0.730 |
| 营业现金流 (OCF TTM) | -12.04 M |
| 杠杆自由现金流 (LFCF TTM) | -7.45 M |
| 资产报酬率 (ROA TTM) | -43.87% |
| 股东权益报酬率 (ROE TTM) | -2,308.32% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | Spectral AI, Inc. | 混合的 | - |
AIStockmoo 评分
-1.3
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -5.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -1.33 |
|
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient’s wound. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 内部持股比例 | 44.27% |
| 机构持股比例 | 21.77% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Highlander Partners, L.P. | 30 Sep 2024 | 900,000 |
| University Of Texas/Texas Am Investment Management Co | 30 Sep 2024 | 210,488 |
| Forum Financial Management, Lp | 30 Sep 2024 | 29,098 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合